Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration

Completed · Phase 2 · Has a placebo group

Conditions studied: Other Abortion, Spontaneous Abortion

In brief

This is a randomized controlled double-blind placebo-controlled trial evaluating the impact of gabapentin given preoperatively on perioperative pain scores for women receiving uterine aspiration between 6 and 14+6 weeks gestation. This study will be a trial included in a prospective meta-analysis evaluating the use of gabapentin on perioperative pain in the abortion setting.

Key facts

Study ID

NCT02725710

Run by

Duke University

People needed

96

Starts

2016-08-01

Expected to finish

2018-06-14

Last updated by the study team

2019-07-02

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women >=18 years-old
• Presenting for a surgical abortion
• No contraindication to outpatient abortion
• No contraindication to gabapentin
• Fluency in English and able to provide informed consent

You may not qualify if…

• Allergy, sensitivity or contraindication to gabapentin
• Severe renal disease
• Currently using gabapentin or pregalabin

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.